داروسازی تولید دارو(سهامی خاص)
دتولید | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/06/13 Fiscal Year 2025/12/2112 Month | 2025/04/19 Fiscal Year 2024/12/2012 Month | 2024/05/25 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 309.105 Billion | 381.961 Billion | 178.597 Billion | |
Trade Receivables | 9.005 Trillion | 6.388 Trillion | 4.661 Trillion | |
Prepayments | - | 317.744 Billion | 504.28 Billion | |
Orders & Prepayments | 818.613 Billion | - | - | |
Raw Materials & Packaging Inventory | 1.367 Trillion | 1.596 Trillion | 1.543 Trillion | |
Work-in-Progress Inventory | 161.84 Billion | 73.45 Billion | 106.212 Billion | |
Finished Goods Inventory | 124.442 Billion | 53.646 Billion | 39.326 Billion | |
Spare Parts Inventory | 98.956 Billion | 104.26 Billion | 113.658 Billion | |
Goods in Transit | 214.308 Billion | 184.468 Billion | 127.327 Billion | |
Our Goods on Consignment with Others | 14.889 Billion | 3.369 Billion | 22.878 Billion | |
Inventories | 1.981 Trillion | 2.015 Trillion | 1.953 Trillion | |
Total Current Assets | 12.114 Trillion | 9.103 Trillion | 7.354 Trillion | |
Long-Term Investments | 134 Million | 31.846 Billion | 74.428 Billion | |
Long-Term Trade Receivables | 7.198 Billion | 7.554 Billion | 16.651 Billion | |
Intangible Assets | 20.586 Billion | 9.371 Billion | 970 Million | |
Property, Plant & Equipment | 2.366 Trillion | 2.467 Trillion | 768.559 Billion | |
Net Fixed Assets | 2.366 Trillion | 2.467 Trillion | 768.559 Billion | |
Total Non-Current Assets | 2.394 Trillion | 2.515 Trillion | 860.608 Billion | |
Total Assets | 14.508 Trillion | 11.618 Trillion | 8.215 Trillion | |
Trade Payables | 5.039 Trillion | 2.537 Trillion | 1.406 Trillion | |
Advances Received | 825.558 Billion | 13.089 Billion | 97.19 Billion | |
Income Tax Provision | 446.991 Billion | 173.215 Billion | 313.373 Billion | |
Proposed & Payable Dividends | 141.252 Billion | 134.176 Billion | 610.452 Billion | |
Current Borrowings | 1.745 Trillion | 2.439 Trillion | 1.937 Trillion | |
Total Current Liabilities | 8.198 Trillion | 5.297 Trillion | 4.364 Trillion | |
Long-Term Payables | 1.397 Trillion | 1.511 Trillion | 346.947 Billion | |
Long-Term Borrowings | 1.2 Trillion | 1.2 Trillion | 1.2 Trillion | |
Employee Termination Benefits Provision | 353.694 Billion | 279.728 Billion | 230.867 Billion | |
Total Non-Current Liabilities | 2.95 Trillion | 2.99 Trillion | 1.778 Trillion | |
Total Liabilities | 11.148 Trillion | 8.287 Trillion | 6.142 Trillion | |
Capital | 3 Trillion | 3 Trillion | 1.2 Trillion | |
Retained Earnings | 255.928 Billion | 308.719 Billion | 802.182 Billion | |
Legal Reserve | 116.058 Billion | 114.623 Billion | 113.401 Billion | |
Share Premium Reserve | -11.711 Billion | -92.482 Billion | -42.647 Billion | |
Total Equity | 3.36 Trillion | 3.331 Trillion | 2.073 Trillion | |
Total Liabilities & Equity | 14.508 Trillion | 11.618 Trillion | 8.215 Trillion | |
Approved Capital | 3 Trillion | 3 Trillion | 1.2 Trillion | |
Approved Retained Earnings | 228.928 Billion | 284.719 Billion | 286.182 Billion | |
Approved Legal Reserve | 116.058 Billion | 114.623 Billion | 113.401 Billion | |
Total Approved Equity (at AGM) | 3.345 Trillion | 3.399 Trillion | 1.6 Trillion | |
Non-Current Assets Held for Sale | - | - | 57.336 Billion |